Sickle Cell Disease and the Promise of India’s First Indigenous CRISPR-based Gene Therapy

Sonali Nagar

IMG

India has recently launched its “first indigenous CRISPR-based Gene Therapy”, called “BIRSA-101”, to treat Sickle Cell Disease (SCD). On 19 November 2025, Hon’ble Union Science and Technology Minister Dr Jitendra Singh unveiled BIRSA-101 at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi…read more NOPR